home / stock / agle / agle news

AGLE News and Press, Aeglea BioTherapeutics Inc. From 01/13/20

Stock Information
Company Name: Aeglea BioTherapeutics Inc.
Stock Symbol: AGLE
Market: NASDAQ
Website: aegleabio.com
Menu
AGLE AGLE Quote AGLE Short AGLE News AGLE Articles AGLE Message Board
Get AGLE Alerts

News, Short Squeeze, Breakout and More Instantly...
AGLE - Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)

AUSTIN, Texas, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing next-generation human enzyme therapeutics as solutions for diseases with high unmet medical need, today announced it has filed a Clinical Trial Appl...
AGLE - Aeglea BioTherapeutics to Present at 38th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing next-generation human enzyme therapeutics as solutions for diseases with high unmet medical need, today announced it will present at the 38 th Annu...

AGLE - Aeglea BioTherapeutics EPS misses by $0.12

Aeglea BioTherapeutics (NASDAQ: AGLE ): Q3 GAAP EPS of -$0.66 misses by $0.12 . More news on: Aeglea BioTherapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

AGLE - Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights

AUSTIN, Texas, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, today reported financial results for the third quarter ...
AGLE - Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C. Hanley as Chief Commercial Officer

AUSTIN, Texas, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, today announced two additions to its senior management ...

AGLE - Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference

AUSTIN, Texas, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, today announced it will present a corporate overview a...

AGLE - Aeglea Bio reports positive data for pegzilarginase in patients with ARGI-D

Aeglea BioTherapeutics (NASDAQ: AGLE ) has presented positive 20-dose data on 14 patients from its completed Phase 1/2 trial and ongoing Phase 2 open-label extension (OLE) trial for pegzilarginase in patients with Arginase 1 Deficiency (ARG1-D) at the 2019 Symposium of the Society for the ...
AGLE - Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

Sustained Control of Plasma Arginine Accompanied by Clinical Response; Overall Clinical Responder Rate of 79% Management to Host Conference Call at 9:00 a.m. ET on Tuesday, September 3 AUSTIN, Texas, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a ...

AGLE - Key events next week - healthcare

Noteworthy events during the week of September 1 - 9 for healthcare investors. More news on: Synlogic, Inc., Orchard Therapeutics plc, Zosano Pharma Corporation, Healthcare stocks news, , Read more ...

AGLE - Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium

AUSTIN, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, today announced it will present new data on all 14 pati...
Previous 10 Next 10